Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update

Published:2022-02 Issue: Volume:343 Page:28-50
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Alsayed Nasreen,Almahmeed Wael,Alnouri Fahad,Al-Waili Khalid,Sabbour Hani,Sulaiman Kadhim,Zubaid Mohammad,Ray Kausik K.,Al-Rasadi Khalid

Funder

National Institute for Health Research

NIHR Imperial Biomedical Research Centre

Amgen

Sanofi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference250 articles.

1. Cardiovascular disease in the asia middle east region: global trends and local implications;Ramahi,2010

2. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden;Turk-Adawi;Nat. Rev. Cardiol.,2018

3. Dyslipidaemia in the Middle East: current status and a call for action;Al Rasadi;Atherosclerosis,2016

4. Prevalence of cardiovascular disease and associated risk factors among adult population in the gulf region: a systematic review;Aljefree;Adv. Publ. Health,2015

5. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Cholesterol Treatment Trialists’ (CTT) Collaboration;Lancet,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis;Acta Pharmacologica Sinica;2024-05-29

2. Evaluation of proprotein convertase subtilsin /kexin 9(PCSK9) in serum of men hypertensive patients;CARDIOMETRY;2024-05-25

3. Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare;Russian Journal of Cardiology;2024-05-25

4. Xantomas;EMC - Dermatología;2024-03

5. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook;Atherosclerosis;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3